医学
干细胞疗法
干细胞
糖尿病
间充质干细胞
祖细胞
细胞疗法
胚胎干细胞
诱导多能干细胞
多发性神经病
骨髓
重症监护医学
外科
生物信息学
内科学
病理
内分泌学
生物
生物化学
遗传学
基因
作者
Shamima Akter,Mayank Choubey,Mohammad Mohabbulla Mohib,Shahida Arbee,Md. Abu Taher Sagor,Mohammad Sarif Mohiuddin
出处
期刊:Brain Sciences
[MDPI AG]
日期:2023-02-02
卷期号:13 (2): 255-255
被引量:15
标识
DOI:10.3390/brainsci13020255
摘要
Diabetic polyneuropathy (DPN) is the most frequent, although neglected, complication of long-term diabetes. Nearly 30% of hospitalized and 20% of community-dwelling patients with diabetes suffer from DPN; the incidence rate is approximately 2% annually. To date, there has been no curable therapy for DPN. Under these circumstances, cell therapy may be a vital candidate for the treatment of DPN. The epidemiology, classification, and treatment options for DPN are disclosed in the current review. Cell-based therapies using bone marrow-derived cells, embryonic stem cells, pluripotent stem cells, endothelial progenitor cells, mesenchymal stem cells, or dental pulp stem cells are our primary concern, which may be a useful treatment option to ease or to stop the progression of DPN. The importance of cryotherapies for treating DPN has been observed in several studies. These findings may help for the future researchers to establish more focused, accurate, effective, alternative, and safe therapy to reduce DPN. Cell-based therapy might be a permanent solution in the treatment and management of diabetes-induced neuropathy.
科研通智能强力驱动
Strongly Powered by AbleSci AI